Skip to main content
Clinical Trials/EUCTR2004-002051-13-GB
EUCTR2004-002051-13-GB
Active, not recruiting
Not Applicable

A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy

Imperial College, London0 sites200 target enrollmentJuly 21, 2005
DrugsCytotec

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Imperial College, London
Enrollment
200
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • All women attending outpatient hysteroscopy clinic.
  • Patients who ahve given written consent for participation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Pregnancy, Patients with endometrial thickness of less than 4mm on ultrasound scan as they do not require a hysteroscopy, Contraindications of hysteroscopy, Contraindications to prostaglandins (patients where an episode of hypotension may be precipitate problems; cardiovascular, cerebrovascular disease and peripheral vascular disease), Patients already taking misoprostol or ArthrotecË (contains 200ºg misoprostol), Cervical abnormalities (false passage, space occupying lesion in cervical canal), Presence of significant uterovaginal prolapse and Failure to obtain informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials